USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells

Abstract Liver fibrosis is a complex fibrotic process that develops early in the course of cirrhosis and is caused by chronic liver damage. The activation of hepatic stellate cells is primarily responsible for the fibrosis process. Studies show that NRP1 influences HSC motility and migration. Howeve...

Full description

Bibliographic Details
Main Authors: Jinqiu Zhao, Jie Bai, Fengling Peng, Chan Qiu, Yongguo Li, Li Zhong
Format: Article
Language:English
Published: Nature Publishing Group 2023-01-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-022-05527-9
_version_ 1797945659968454656
author Jinqiu Zhao
Jie Bai
Fengling Peng
Chan Qiu
Yongguo Li
Li Zhong
author_facet Jinqiu Zhao
Jie Bai
Fengling Peng
Chan Qiu
Yongguo Li
Li Zhong
author_sort Jinqiu Zhao
collection DOAJ
description Abstract Liver fibrosis is a complex fibrotic process that develops early in the course of cirrhosis and is caused by chronic liver damage. The activation of hepatic stellate cells is primarily responsible for the fibrosis process. Studies show that NRP1 influences HSC motility and migration. However, whether NRP1 regulates HSC activation remains unknown. C57BL/6 male mice (6–8 weeks old) were intraperitoneally injected with 10% CCl4 in olive oil (5 μl/g body weight) every three days for four weeks to create an animal model of liver fibrosis. Control mice received olive oil (5 μl/g body weight). Different assays such as immunohistochemistry, immunostaining, Western blotting, qRT-PCR, immunoprecipitation, immunoprecipitation, and GST pull-down assays, and in vivo and in vitro ubiquitination assays were conducted. We found that NRP1 expression was significantly elevated both in mouse and human fibrotic livers, mainly in activated HSCs at the fibrotic foci. NRP1 promoted HSC activation via the cytokine TGF-β1, VEGFA, and PDGF-BB. Moreover, USP9X was found to be a critical deubiquitinating enzyme for the stability and high activity of NRP1 and NRP1 deubiquitination mediated by USP9X enhanced HSC activation and liver fibrosis. NRP1 deubiquitination mediated by USP9X enhances HSC activation, implying that targeting NRP1 or USP9X potentiates novel options in the treatment of liver fibrosis.
first_indexed 2024-04-10T20:58:37Z
format Article
id doaj.art-34ff8ff5cfcf4ab6b756bdd0c28ad8cc
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-04-10T20:58:37Z
publishDate 2023-01-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-34ff8ff5cfcf4ab6b756bdd0c28ad8cc2023-01-22T12:26:40ZengNature Publishing GroupCell Death and Disease2041-48892023-01-0114111010.1038/s41419-022-05527-9USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cellsJinqiu Zhao0Jie Bai1Fengling Peng2Chan Qiu3Yongguo Li4Li Zhong5Department of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical UniversityDepartment of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical UniversityDepartment of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical UniversityDepartment of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical UniversityDepartment of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical UniversityDepartment of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical UniversityAbstract Liver fibrosis is a complex fibrotic process that develops early in the course of cirrhosis and is caused by chronic liver damage. The activation of hepatic stellate cells is primarily responsible for the fibrosis process. Studies show that NRP1 influences HSC motility and migration. However, whether NRP1 regulates HSC activation remains unknown. C57BL/6 male mice (6–8 weeks old) were intraperitoneally injected with 10% CCl4 in olive oil (5 μl/g body weight) every three days for four weeks to create an animal model of liver fibrosis. Control mice received olive oil (5 μl/g body weight). Different assays such as immunohistochemistry, immunostaining, Western blotting, qRT-PCR, immunoprecipitation, immunoprecipitation, and GST pull-down assays, and in vivo and in vitro ubiquitination assays were conducted. We found that NRP1 expression was significantly elevated both in mouse and human fibrotic livers, mainly in activated HSCs at the fibrotic foci. NRP1 promoted HSC activation via the cytokine TGF-β1, VEGFA, and PDGF-BB. Moreover, USP9X was found to be a critical deubiquitinating enzyme for the stability and high activity of NRP1 and NRP1 deubiquitination mediated by USP9X enhanced HSC activation and liver fibrosis. NRP1 deubiquitination mediated by USP9X enhances HSC activation, implying that targeting NRP1 or USP9X potentiates novel options in the treatment of liver fibrosis.https://doi.org/10.1038/s41419-022-05527-9
spellingShingle Jinqiu Zhao
Jie Bai
Fengling Peng
Chan Qiu
Yongguo Li
Li Zhong
USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells
Cell Death and Disease
title USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells
title_full USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells
title_fullStr USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells
title_full_unstemmed USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells
title_short USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells
title_sort usp9x mediated nrp1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells
url https://doi.org/10.1038/s41419-022-05527-9
work_keys_str_mv AT jinqiuzhao usp9xmediatednrp1deubiquitinationpromotesliverfibrosisbyactivatinghepaticstellatecells
AT jiebai usp9xmediatednrp1deubiquitinationpromotesliverfibrosisbyactivatinghepaticstellatecells
AT fenglingpeng usp9xmediatednrp1deubiquitinationpromotesliverfibrosisbyactivatinghepaticstellatecells
AT chanqiu usp9xmediatednrp1deubiquitinationpromotesliverfibrosisbyactivatinghepaticstellatecells
AT yongguoli usp9xmediatednrp1deubiquitinationpromotesliverfibrosisbyactivatinghepaticstellatecells
AT lizhong usp9xmediatednrp1deubiquitinationpromotesliverfibrosisbyactivatinghepaticstellatecells